Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Inv. presentation
Appointed director
|
|
Diadexus, Inc. (DDXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2018 |
SC 13G/A
| MORGAN STANLEY reports a 0% stake in Diadexus, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2016 |
10-Q
| Quarterly Report for the period ended March 31, 2016 |
| 04/28/2016 |
8-K
| Quarterly results |
| 04/18/2016 |
8-K
| Form 8-K - Current report |
| 04/01/2016 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
| 03/29/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/28/2016 |
8-K
| Quarterly results |
| 03/17/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/30/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 10/26/2015 |
8-K
| Quarterly results |
| 09/08/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities |
| 08/20/2015 |
8-K
| Regulation FD Disclosure |
| 08/13/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 08/13/2015 |
8-K
| Quarterly results |
| 07/02/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/01/2015 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 06/10/2015 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/13/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
| 05/12/2015 |
8-K
| Quarterly results |
| 04/30/2015 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/30/2015 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 04/22/2015 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Lori Rafield, Ph.D. Appointed Permanent CEO of Diadexus SOUTH SAN FRANCISCO, Calif., April 20, 2015 -- Diadexus, Inc. , a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced the appointment of Lori F. Rafield, Ph.D. as chief executive officer of the Company on a permanent basis, effective immediately. Dr. Rafield has continued to serve as chairman since 2010. She assumed the responsibility of interim executive chair in June 2014 and then was appointed interim chief executive officer in January 2015. “Lori has assembled a leadership team with deep operating experience and we are pleased she has agreed to lead this team as Diadexus' permanent chief executive officer,” said Karen Drexler, independent director of the b..." |
|
| 04/17/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 03/12/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/12/2015 |
8-K
| Quarterly results |
| 03/09/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"diaDexus, Inc. Announces Appointment of Leone Patterson as Chief Financial Officer SOUTH SAN FRANCISCO, Calif., March 2, 2015 — diaDexus, Inc. , a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of Leone Patterson as chief financial officer. “We are fortunate to have Leone join our new leadership team as we work together to create value through evolving diaDexus into a multi-product company with significant growth potential,” said Lori Rafield, Ph.D., chairman of the board of directors and interim chief executive officer of diaDexus. “Leone has extensive financial, accounting, and business experience, gained in roles of increasing responsibility at Net App, Exelixis, Novartis, Chiron, and KPMG. Most recently, she was th..." |
|
| 03/02/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"diaDexus, Inc. Announces Appointment of John Curnutte, M.D., Ph.D. to its Board of Directors SOUTH SAN FRANCISCO, Calif., February 24, 2015 — diaDexus, Inc. , a company developing and commercializing proprietary cardiovascular diagnostic products, today announced the appointment of John Curnutte, M.D., Ph.D. as an independent member of its board of directors effective immediately. Dr. Curnutte will serve on the compensation committee. The Company also announced that Adeoye Olukotun, M.D. does not plan to stand for reelection at the 2015 Annual Meeting of Stockholders. “John brings extensive clinical development expertise to diaDexus, and we are delighted to have him join our Board of Directors,” said Lori Rafield, Ph.D., chairman of the board and interim chief executive officer for diaDexu..." |
|
| 02/11/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/07/2015 |
8-K
| Resignation/termination of a director |
| 01/05/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/29/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/18/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|